Brief AI Glossary Can Help Clinical Lab Managers Navigate a Litany of Terms
We explain what ‘tokens’ are, as well as what ‘GPT’ really means
Author Information
We explain what ‘tokens’ are, as well as what ‘GPT’ really means
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
The free online tool can set a foundation for renewed reimbursement strategies and contract negotiations with insurance carriers
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Lab scientists using testing equipment too quickly brings up training concerns in discussions at recent ADLM conference
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing